Logos Global Master Fund LP 13D and 13G filings for Larimar Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 4:47 pm Purchase | 2021-02-04 | 13G | Larimar Therapeutics, Inc. LRMR | Logos Global Master Fund LP | 300,000 2.000% | 300,000 (New Position) | Filing |